A new trading day began on Tuesday, with Perspective Therapeutics Inc (AMEX: CATX) stock price down -11.78% from the previous day of trading, before settling in for the closing price of $3.48. CATX’s price has ranged from $2.52 to $19.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 53.61%. With a float of $48.92 million, this company’s outstanding shares have now reached $67.56 million.
The extent of productivity of a business whose workforce counts for 119 workers is very important to gauge. In terms of profitability, gross margin is 100.0%, operating margin of -15937.09%, and the pretax margin is -13973.89%.
Perspective Therapeutics Inc (CATX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 27.62%, while institutional ownership is 75.59%. The most recent insider transaction that took place on Dec 04 ’24, was worth 100,004. In this transaction Director of this company bought 25,975 shares at a rate of $3.85, taking the stock ownership to the 25,975 shares. Before that another transaction happened on Dec 04 ’24, when Company’s CEO bought 8,000 for $3.77, making the entire transaction worth $30,132. This insider now owns 36,257 shares in total.
Perspective Therapeutics Inc (CATX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.61% per share during the next fiscal year.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Here are Perspective Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
The latest stats from [Perspective Therapeutics Inc, CATX] show that its last 5-days average volume of 1.47 million was superior to 0.87 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 20.69%. Additionally, its Average True Range was 0.55.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 0.96%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.26% in the past 14 days, which was lower than the 139.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.58, while its 200-day Moving Average is $12.31. Now, the first resistance to watch is $3.34. This is followed by the second major resistance level at $3.60. The third major resistance level sits at $3.74. If the price goes on to break the first support level at $2.94, it is likely to go to the next support level at $2.80. Assuming the price breaks the second support level, the third support level stands at $2.54.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
With a market capitalization of 207.49 million, the company has a total of 67,588K Shares Outstanding. Currently, annual sales are 1,430 K while annual income is -46,510 K. The company’s previous quarter sales were 370 K while its latest quarter income was -15,120 K.
